368870-65-9

Basic information

• Product Name: (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid
• Synonyms: (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid
• CAS NO: 368870-65-9
• Molecular Weight: 307.39
• Mol File: 368870-65-9.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid(368870-65-9)
• EPA Substance Registry System: (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid(368870-65-9)

Safety Data

• Hazardous Substances Data: 368870-65-9(Hazardous Substances Data)

Usage

General Description

The chemical (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid is a compound with the structural formula C16H23NO4. It is also known by the systematic name (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid and is commonly used as a building block in the synthesis of peptides. (2S,4R)-4-((tert-butoxycarbonyl)amino)-2-methyl-5-phenylpentanoic acid is a derivative of the natural amino acid leucine and is often used as a protecting group for the amine functional group. It is commonly used in organic chemistry and biochemistry research to help modify and control the reactivity of amino acids and peptides.

Upstream product

• 1173283-52-7 C₂₃H₃₄N₂O₅ 
• 24424-99-5 di-tert-butyl dicarbonate 
• 368870-63-7 (3R,5R)-tert-butyl 5-benzyl-3-methyl-2-oxopyrrolidine-1-carboxylate 
• 2174-58-5 L-malic acid 
• 1589-82-8 phenylmagnesium bromide 
• 6973-20-2 (S)-methylsuccinic anhydride 
• 71535-50-7 (S)-(+)-2-benzyl-1-(p-tolylsulfonyl)aziridine 
• 1333145-78-0 (3S,5R)-5-benzyl-3-methylpyrrolidin-2-one 
• 3182-95-4 L-Phenylalaninol 
• 63-91-2 L-phenylalanine 
• 862387-31-3 (S)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methyl-butyric acid 
• 204917-42-0 (3S)-4-(tert-butyldimethylsilanyloxy)-3-methylbutyraldehyde 
• 796039-47-9 (1R,3S)-(1-benzyl-4-hydroxy-3-methylbutyl)carbamic acid tert-butyl ester 

Downstream Products

• 1017624-85-9 (R)-4-tert-butoxycarbonylamino-3-methyl-5-phenylpentanoic acid benzyl ester 
• 919518-59-5 methyl (2S,4R)-4-{[(2-{(1R,3R)-3-[(tert-butoxycarbonyl)amino]-1-hydroxy-4-methylpentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoate 
• 1423040-35-0 methyl (2S,4R)-4-{[(2-{(1R,3R)-1-acetoxy-3-[(tert-butoxycarbonyl)amino]-4-methylpentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoate 
• 1423040-49-6 methyl (2S,4R)-4-{[(2-{(6S,9R,11R)-6-[(2S)-butan-2-yl]-9-isopropyl-2,2-dimethyl-4,7,13-trioxo-3,12-dioxa-5,8-diazatetradecan-11-yl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoate 
• 1423040-36-1 (R)-benzyl 2-((2S,3S)-1-((1R,3R)-1-acetoxy-1-(4-((2R,4S)-5-methoxy-4-methyl-5-oxo-1-phenylpentan-2-ylcarbamoyl)thiazol-2-yl)-4-methylpentan-3-ylamino)-3-methyl-1-oxopentan-2-ylcarbamoyl)piperidine-1-carboxylate 
• 919518-62-0 methyl (2S,4R)-4-[({2-[(1R,3R)-1-acetoxy-4-methyl-3-{[(2S,3S)-3-methyl-2-({[(2R)-1-methylpiperidin-2-yl]carbonyl}amino)pentanoyl]amino}pentyl]-1,3-thiazol-4-yl}carbonyl)amino]-2-methyl-5-phenylpentanoate 
• 1423117-90-1 C₂₅H₃₅N₃O₅S 
• 943218-34-6 4-({2-[1-acetoxy-3-(2-amino-3-methyl-pentanoylamino)-4-methyl-pentyl]-thiazole-4-carbonyl}-amino)-2-methyl-5-phenyl-pentanoic acid methyl ester 
• 1423040-41-8 C₃₇H₅₅N₅O₇S 
• 919518-38-0 methyl (2S,4R)-4-[(tert-butoxycarbonyl)amino]-2-methyl-5-phenylpentanoate 
• 1101181-32-1 C₄₂H₅₉N₅O₆S 
• 1101181-34-3 C₄₀H₅₆N₄O₇S 

Relevant articles and documents

Tubulysin Synthesis Featuring Stereoselective Catalysis and Highly Convergent Multicomponent Assembly

A concise and modular total synthesis of the highly potent N14-desacetoxytubulysin H (1) has been accomplished in 18 steps in an overall yield of up to 30percent. Our work highlights the complexity-augmenting and route-shortening power of diastereoselective multicomponent reaction (MCR) as well as the role of bulky ligands to perfectly control both the regioselective and diastereoselective synthesis of tubuphenylalanine in just two steps. The total synthesis not only provides an operationally simple and step economy but will also stimulate major advances in the development of new tubulysin analogues.

CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME

Compounds of general formula (I) having cytotoxic and/or anti-mitotic activity and methods of using such compounds, as well as pharmaceutical compositions comprising such compounds. The compounds may also be conjugated with a targeting moiety, such as an

Stereoselective total synthesis of tubulysin v

The total synthesis of tubulysin V was accomplished in 1.0% overall yield with linear 13 steps. Our synthetic strategy featured the following two reactions. One is zinc-mediated aza-Barbier reaction of (R)-N-tert- butanesulfinyl imine 8 with β-ester group functionalized allylic bromide 9 to afford the chiral homo-allylic amine (7); the other is to employ the methodology of aqueous indium-mediated aza-Barbier reaction previously developed by our group, giving the chiral homo-allylic amine 13 with high efficiency. The total synthesis of tubulysin V was accomplished in 1.0% overall yield with linear 13 steps. Our synthetic strategy featured the following two reactions. One is zinc-mediated aza-Barbier reaction of (R)-N-tert-butanesulfinyl imine 8 with β-ester group functionalized allylic bromide 9 to afford the chiral homo-allylic amine 7; the other is to employ the methodology of aqueous indium-mediated aza-Barbier reaction previously developed by our group, giving the chiral homo-allylic amine 13 with high efficiency. Copyright